Drug Shortage Report for CEFTRIAXONE FOR INJECTION

Last updated on 2020-01-16 History
Report ID 57919
Drug Identification Number 02409968
Brand name CEFTRIAXONE FOR INJECTION
Common or Proper name CefTRIAXone for Injection
Company Name FRESENIUS KABI CANADA LTD
Active Ingredient(s) CEFTRIAXONE
Strength(s) 100G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 100g SmartPak
ATC code J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-07-13
Actual start date
Estimated end date Unknown
Actual end date 2018-11-14
Shortage status Resolved
Updated date 2020-01-16
Company comments
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-01-16 French Compare
v5 2020-01-16 English Compare
v4 2018-11-02 French Compare
v3 2018-11-02 English Compare
v2 2018-08-10 French Compare
v1 2018-08-10 English Compare